List of Tables
    Table 1. Synthetic Lethality-based Drugs and Targets Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Synthetic Lethality-based Drugs and Targets Market Trends
    Table 3. Synthetic Lethality-based Drugs and Targets Market Drivers
    Table 4. Synthetic Lethality-based Drugs and Targets Market Challenges
    Table 5. Synthetic Lethality-based Drugs and Targets Market Restraints
    Table 6. Global Synthetic Lethality-based Drugs and Targets Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Synthetic Lethality-based Drugs and Targets Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Synthetic Lethality-based Drugs and Targets Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Synthetic Lethality-based Drugs and Targets Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Synthetic Lethality-based Drugs and Targets Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Synthetic Lethality-based Drugs and Targets Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Player, 2017-2022
    Table 13. Global Synthetic Lethality-based Drugs and Targets Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Synthetic Lethality-based Drugs and Targets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2021)
    Table 15. Top Players of Synthetic Lethality-based Drugs and Targets in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Synthetic Lethality-based Drugs and Targets Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Synthetic Lethality-based Drugs and Targets Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Synthetic Lethality-based Drugs and Targets Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Synthetic Lethality-based Drugs and Targets Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Synthetic Lethality-based Drugs and Targets Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Synthetic Lethality-based Drugs and Targets Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Synthetic Lethality-based Drugs and Targets Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Synthetic Lethality-based Drugs and Targets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Synthetic Lethality-based Drugs and Targets Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Synthetic Lethality-based Drugs and Targets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Synthetic Lethality-based Drugs and Targets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Synthetic Lethality-based Drugs and Targets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. AbbVie Company Details
    Table 31. AbbVie Business Overview
    Table 32. AbbVie Synthetic Lethality-based Drugs and Targets Product
    Table 33. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 34. AbbVie Recent Development
    Table 35. AstraZeneca Company Details
    Table 36. AstraZeneca Business Overview
    Table 37. AstraZeneca Synthetic Lethality-based Drugs and Targets Product
    Table 38. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 39. AstraZeneca Recent Development
    Table 40. BeiGene Company Details
    Table 41. BeiGene Business Overview
    Table 42. BeiGene Synthetic Lethality-based Drugs and Targets Product
    Table 43. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 44. BeiGene Recent Development
    Table 45. Clovis Oncology Company Details
    Table 46. Clovis Oncology Business Overview
    Table 47. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product
    Table 48. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 49. Clovis Oncology Recent Development
    Table 50. GlaxoSmithKline Company Details
    Table 51. GlaxoSmithKline Business Overview
    Table 52. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product
    Table 53. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 54. GlaxoSmithKline Recent Development
    Table 55. Pfizer Company Details
    Table 56. Pfizer Business Overview
    Table 57. Pfizer Synthetic Lethality-based Drugs and Targets Product
    Table 58. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 59. Pfizer Recent Development
    Table 60. AtlasMedx Company Details
    Table 61. AtlasMedx Business Overview
    Table 62. AtlasMedx Synthetic Lethality-based Drugs and Targets Product
    Table 63. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 64. AtlasMedx Recent Development
    Table 65. Chordia Therapeutics Company Details
    Table 66. Chordia Therapeutics Business Overview
    Table 67. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 68. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 69. Chordia Therapeutics Recent Development
    Table 70. IDEAYA Biosciences Company Details
    Table 71. IDEAYA Biosciences Business Overview
    Table 72. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product
    Table 73. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 74. IDEAYA Biosciences Recent Development
    Table 75. Mission Therapeutics Company Details
    Table 76. Mission Therapeutics Business Overview
    Table 77. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 78. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 79. Mission Therapeutics Recent Development
    Table 80. Repare Therapeutics Company Details
    Table 81. Repare Therapeutics Business Overview
    Table 82. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 83. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 84. Repare Therapeutics Recent Development
    Table 85. Sierra Oncology Company Details
    Table 86. Sierra Oncology Business Overview
    Table 87. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product
    Table 88. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 89. Sierra Oncology Recent Development
    Table 90. SyntheX Labs Company Details
    Table 91. SyntheX Labs Business Overview
    Table 92. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product
    Table 93. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2017-2022) & (US$ Million)
    Table 94. SyntheX Labs Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Synthetic Lethality-based Drugs and Targets Product Picture
    Figure 2. Global Synthetic Lethality-based Drugs and Targets Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Synthetic Lethality-based Drugs and Targets Market Size 2017-2028 (US$ Million)
    Figure 4. United States Synthetic Lethality-based Drugs and Targets Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Synthetic Lethality-based Drugs and Targets Market Size 2017-2028 (US$ Million)
    Figure 6. United States Synthetic Lethality-based Drugs and Targets Market Share in Global 2017-2028
    Figure 7. Synthetic Lethality-based Drugs and Targets Report Years Considered
    Figure 8. Product Picture of Monotherapy
    Figure 9. Product Picture of Combination Therapy
    Figure 10. Global Synthetic Lethality-based Drugs and Targets Market Share by Type in 2022 & 2028
    Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Synthetic Lethality-based Drugs and Targets Market Share by Type (2017-2028)
    Figure 13. United States Synthetic Lethality-based Drugs and Targets Market Share by Type in 2022 & 2028
    Figure 14. United States Synthetic Lethality-based Drugs and Targets Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Synthetic Lethality-based Drugs and Targets Market Share by Type (2017-2028)
    Figure 16. Product Picture of Medical Research Institution
    Figure 17. Product Picture of Hospital and Clinic
    Figure 18. Product Picture of Other
    Figure 19. Global Synthetic Lethality-based Drugs and Targets Market Share by Application in 2022 & 2028
    Figure 20. Global Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Synthetic Lethality-based Drugs and Targets Market Share by Application (2017-2028)
    Figure 22. United States Synthetic Lethality-based Drugs and Targets Market Share by Application in 2022 & 2028
    Figure 23. United States Synthetic Lethality-based Drugs and Targets Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Synthetic Lethality-based Drugs and Targets Market Share by Application (2017-2028)
    Figure 25. North America Synthetic Lethality-based Drugs and Targets Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Synthetic Lethality-based Drugs and Targets Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Synthetic Lethality-based Drugs and Targets Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 54. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 55. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 56. Clovis Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 57. GlaxoSmithKline Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 58. Pfizer Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 59. AtlasMedx Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 60. Chordia Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 61. IDEAYA Biosciences Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 62. Mission Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 63. Repare Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 64. Sierra Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 65. SyntheX Labs Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed